PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $265,530 | +111.0% | 31,800 | +106.7% | 0.00% | +50.0% |
| Q4 2022 | $125,825 | -7.6% | 15,382 | -67.2% | 0.00% | 0.0% |
| Q3 2022 | $136,136 | +6.4% | 46,890 | +97.9% | 0.00% | -60.0% |
| Q3 2018 | $128,000 | +52.4% | 23,697 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $84,000 | +71.4% | 23,697 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $49,000 | -53.8% | 23,697 | +58.0% | 0.00% | -71.4% |
| Q2 2016 | $106,000 | +10.4% | 15,000 | -9.6% | 0.01% | -17.6% |
| Q2 2015 | $96,000 | -86.7% | 16,585 | -88.0% | 0.02% | -86.7% |
| Q4 2013 | $721,000 | +300.6% | 137,918 | +324.0% | 0.13% | +374.1% |
| Q3 2013 | $180,000 | +29.5% | 32,524 | -41.1% | 0.03% | +3.8% |
| Q2 2013 | $139,000 | – | 55,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |